Selected research
Industry Research
Long Read Sequencing Industry Research Report 2026
Market perspective
The global Long Read Sequencing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Long Read Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Long Read Sequencing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Long Read Sequencing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Long Read Sequencing include Oxford Nanopore Technologies, Pacific Biosciences of California, BaseClear B.V., Future Genomics Technologies, Garvan Institute of Medical Research, Genome Transcriptome Facility of Bordeaux, NextOmics, Takara Bio and Quantapore, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Long Read Sequencing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Long Read Sequencing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Long Read Sequencing Market by Company
Oxford Nanopore Technologies
Pacific Biosciences of California
BaseClear B.V.
Future Genomics Technologies
Garvan Institute of Medical Research
Genome Transcriptome Facility of Bordeaux
NextOmics
Takara Bio
Quantapore
Roche
MicrobesNG
Institute of Integrative Biology of the Cell
Long Read Sequencing Segment by Type
Consumables
Instruments
Services
Long Read Sequencing Segment by Application
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other
Long Read Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long Read Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Long Read Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long Read Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Long Read Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Consumables
- Instruments
- Services
Applications
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other
Companies covered
- Oxford Nanopore Technologies
- Pacific Biosciences of California
- BaseClear B.V.
- Future Genomics Technologies
- Garvan Institute of Medical Research
- Genome Transcriptome Facility of Bordeaux
- NextOmics
- Takara Bio
- Quantapore
- Roche
- MicrobesNG
- Institute of Integrative Biology of the Cell
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Long Read Sequencing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Consumables
- 2.2.3 Instruments
- 2.2.4 Services
- 2.3 Long Read Sequencing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Academic Research
- 2.3.3 Clinical Research
- 2.3.4 Hospitals & Clinics
- 2.3.5 Pharma & Biotech Entities
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Long Read Sequencing Breakdown Data by Type
- 3.1 Global Long Read Sequencing Historic Market Size by Type (2021-2026)
- 3.2 Global Long Read Sequencing Forecasted Market Size by Type (2027-2032)
4 Long Read Sequencing Breakdown Data by Application
- 4.1 Global Long Read Sequencing Historic Market Size by Application (2021-2026)
- 4.2 Global Long Read Sequencing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Long Read Sequencing Market Perspective (2021-2032)
- 5.2 Global Long Read Sequencing Growth Trends by Region
- 5.2.1 Global Long Read Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Long Read Sequencing Historic Market Size by Region (2021-2026)
- 5.2.3 Long Read Sequencing Forecasted Market Size by Region (2027-2032)
- 5.3 Long Read Sequencing Market Dynamics
- 5.3.1 Long Read Sequencing Industry Trends
- 5.3.2 Long Read Sequencing Market Drivers
- 5.3.3 Long Read Sequencing Market Challenges
- 5.3.4 Long Read Sequencing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Long Read Sequencing Players by Revenue
- 6.1.1 Global Top Long Read Sequencing Players by Revenue (2021-2026)
- 6.1.2 Global Long Read Sequencing Revenue Market Share by Players (2021-2026)
- 6.2 Global Long Read Sequencing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Long Read Sequencing Head Office and Area Served
- 6.4 Global Long Read Sequencing Players, Product Type & Application
- 6.5 Global Long Read Sequencing Manufacturers Established Date
- 6.6 Global Long Read Sequencing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Long Read Sequencing Market Size (2021-2032)
- 7.2 North America Long Read Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Long Read Sequencing Market Size by Country (2021-2026)
- 7.4 North America Long Read Sequencing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Long Read Sequencing Market Size (2021-2032)
- 8.2 Europe Long Read Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Long Read Sequencing Market Size by Country (2021-2026)
- 8.4 Europe Long Read Sequencing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Long Read Sequencing Market Size (2021-2032)
- 9.2 Asia-Pacific Long Read Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Long Read Sequencing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Long Read Sequencing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Long Read Sequencing Market Size (2021-2032)
- 10.2 South America Long Read Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Long Read Sequencing Market Size by Country (2021-2026)
- 10.4 South America Long Read Sequencing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Long Read Sequencing Market Size (2021-2032)
- 11.2 Middle East & Africa Long Read Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Long Read Sequencing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Long Read Sequencing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Oxford Nanopore Technologies
- 12.1.1 Oxford Nanopore Technologies Company Information
- 12.1.2 Oxford Nanopore Technologies Business Overview
- 12.1.3 Oxford Nanopore Technologies Revenue in Long Read Sequencing Business (2021-2026)
- 12.1.4 Oxford Nanopore Technologies Long Read Sequencing Product Portfolio
- 12.1.5 Oxford Nanopore Technologies Recent Developments
- 12.2 Pacific Biosciences of California
- 12.2.1 Pacific Biosciences of California Company Information
- 12.2.2 Pacific Biosciences of California Business Overview
- 12.2.3 Pacific Biosciences of California Revenue in Long Read Sequencing Business (2021-2026)
- 12.2.4 Pacific Biosciences of California Long Read Sequencing Product Portfolio
- 12.2.5 Pacific Biosciences of California Recent Developments
- 12.3 BaseClear B.V.
- 12.3.1 BaseClear B.V. Company Information
- 12.3.2 BaseClear B.V. Business Overview
- 12.3.3 BaseClear B.V. Revenue in Long Read Sequencing Business (2021-2026)
- 12.3.4 BaseClear B.V. Long Read Sequencing Product Portfolio
- 12.3.5 BaseClear B.V. Recent Developments
- 12.4 Future Genomics Technologies
- 12.4.1 Future Genomics Technologies Company Information
- 12.4.2 Future Genomics Technologies Business Overview
- 12.4.3 Future Genomics Technologies Revenue in Long Read Sequencing Business (2021-2026)
- 12.4.4 Future Genomics Technologies Long Read Sequencing Product Portfolio
- 12.4.5 Future Genomics Technologies Recent Developments
- 12.5 Garvan Institute of Medical Research
- 12.5.1 Garvan Institute of Medical Research Company Information
- 12.5.2 Garvan Institute of Medical Research Business Overview
- 12.5.3 Garvan Institute of Medical Research Revenue in Long Read Sequencing Business (2021-2026)
- 12.5.4 Garvan Institute of Medical Research Long Read Sequencing Product Portfolio
- 12.5.5 Garvan Institute of Medical Research Recent Developments
- 12.6 Genome Transcriptome Facility of Bordeaux
- 12.6.1 Genome Transcriptome Facility of Bordeaux Company Information
- 12.6.2 Genome Transcriptome Facility of Bordeaux Business Overview
- 12.6.3 Genome Transcriptome Facility of Bordeaux Revenue in Long Read Sequencing Business (2021-2026)
- 12.6.4 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Product Portfolio
- 12.6.5 Genome Transcriptome Facility of Bordeaux Recent Developments
- 12.7 NextOmics
- 12.7.1 NextOmics Company Information
- 12.7.2 NextOmics Business Overview
- 12.7.3 NextOmics Revenue in Long Read Sequencing Business (2021-2026)
- 12.7.4 NextOmics Long Read Sequencing Product Portfolio
- 12.7.5 NextOmics Recent Developments
- 12.8 Takara Bio
- 12.8.1 Takara Bio Company Information
- 12.8.2 Takara Bio Business Overview
- 12.8.3 Takara Bio Revenue in Long Read Sequencing Business (2021-2026)
- 12.8.4 Takara Bio Long Read Sequencing Product Portfolio
- 12.8.5 Takara Bio Recent Developments
- 12.9 Quantapore
- 12.9.1 Quantapore Company Information
- 12.9.2 Quantapore Business Overview
- 12.9.3 Quantapore Revenue in Long Read Sequencing Business (2021-2026)
- 12.9.4 Quantapore Long Read Sequencing Product Portfolio
- 12.9.5 Quantapore Recent Developments
- 12.10 Roche
- 12.10.1 Roche Company Information
- 12.10.2 Roche Business Overview
- 12.10.3 Roche Revenue in Long Read Sequencing Business (2021-2026)
- 12.10.4 Roche Long Read Sequencing Product Portfolio
- 12.10.5 Roche Recent Developments
- 12.11 MicrobesNG
- 12.11.1 MicrobesNG Company Information
- 12.11.2 MicrobesNG Business Overview
- 12.11.3 MicrobesNG Revenue in Long Read Sequencing Business (2021-2026)
- 12.11.4 MicrobesNG Long Read Sequencing Product Portfolio
- 12.11.5 MicrobesNG Recent Developments
- 12.12 Institute of Integrative Biology of the Cell
- 12.12.1 Institute of Integrative Biology of the Cell Company Information
- 12.12.2 Institute of Integrative Biology of the Cell Business Overview
- 12.12.3 Institute of Integrative Biology of the Cell Revenue in Long Read Sequencing Business (2021-2026)
- 12.12.4 Institute of Integrative Biology of the Cell Long Read Sequencing Product Portfolio
- 12.12.5 Institute of Integrative Biology of the Cell Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst